Tag

Tag: MSD

28/05/2020 3 mins

MSD Enters Covid-19 Vaccine Race by Acquiring Themis Bioscience

22/08/2019 2 mins

Austrian Vaccine Developer Signs Deal with MSD in ‘Blockbuster Indication’

09/04/2018 4 mins

Are PD-1 and PD-L1 Checkpoint Inhibitors As Good As We Thought?

06/09/2017 1 min

MSD Offers €464M to Buy German Biotech Fighting Cancer with RNA

18/08/2017 1 min

AstraZeneca and MSD Expand Use of Oral Ovarian Cancer Drug

12/06/2017 2 mins

German Biotech Unveils Positive Phase II Results for Alzheimer’s

16/05/2017 2 mins

Berlin Biotech Advances its Cancer Drug in a New Trial with Keytruda

We use cookies to give you the best experience. If you click on accept, we also use tracking cookies for analytics and advertising purposes. Check our privacy policy for more details. By accepting, you support our independent media and its’ freely accessible content. You may withdraw your consent at any time.

AI Drug Discovery Firm Exscientia Closes €54M Series C

Argenx Follows up Phase III Success with Giant €785M Global Offering